Neurona Therapeutics

Drug Discovery · South San Francisco, CA · Founded 2008 · Privately Held (backing)

Developer of regenerative cell therapies designed for the treatment of chronic neurological disorders. Neurona Therapeutics is based in South San Francisco, CA and was founded in 2008. It is valued at about $1.1 billion as of Oct 2026, set by institutional fund marks. It has raised $348 million across 6 recorded rounds; the latest was a $102 million Series F in Mar 2025.

PMV mark · valuation
$1.1B
Oct 2026
Priced at
a merger or acquisition
Apr 2026
Total raised
$347.6M
Last round
Later Stage VC (Series F)
Mar 2025
How much has Neurona Therapeutics raised?
$347.6Macross 6 recorded rounds · Dec 2014 – Mar 2025

Most recently, Neurona Therapeutics raised $101.7M in its Later Stage VC (Series F) (Mar 2025).

Free account
More of Neurona Therapeutics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Neurona Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Neurona Therapeutics round by round

6 rounds
Mar 2025Later Stage VC (Series F)$101.7M▮
+ 2 more investors · free account
Feb 2024Later Stage VC (Series E)$120.0M▮
+ 1 more investors · free account
Mar 2021Later Stage VC$72.0MSEC filing▮
21 investors participated
Nov 2019Early Stage VC$15.0MSEC filing▮
9 investors participated
Feb 2018Early Stage VC$10.0MSEC filing▮
6 investors participated
Dec 2014Early Stage VC$28.7MSEC filing▮
13 investors participated

How much has Neurona Therapeutics raised?

Neurona Therapeutics has raised $348 million across 6 recorded rounds since 2014. The largest was a $72 million later-stage round in Mar 2021; the most recent was a $102 million Series F in Mar 2025.

Neurona Therapeutics has filed 8 Form Ds with the SEC since 2014, most recently in Apr 2025 ($102 million sold to 46 investors).

Neurona Therapeutics investors

30 investors are on record for Neurona Therapeutics, including Fidelity Management & Research Company, Viking Global Investors, National Institutes of Health and University of California. The Series F in Mar 2025 drew 15 investors.

For fundraisers
Raising for a company like Neurona Therapeutics?

30 investors have backed Neurona Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 30 investors →

Frequently asked about Neurona Therapeutics

How much has Neurona Therapeutics raised?
Neurona Therapeutics has raised $347.6M in total across 6 recorded funding rounds.
When was Neurona Therapeutics's last funding round?
Neurona Therapeutics's most recent recorded round was Later Stage VC (Series F) in Mar 2025, raising $101.7M.